WP
VERA icon

Woodline Partners’s Vera Therapeutics VERA Stock Holding History

Woodline Partners’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40.3M Buy
1,001,037
+758
+0.1% +$32.7K 0.15% 173
2025
Q4 		$50.7M Buy
1,000,279
+262,701
+36% +$9.33M 0.2% 124
2025
Q3 		$21.4M Sell
737,578
-1,870,794
-72% -$43.3M 0.1% 269
2025
Q2 		$61.5M Buy
2,608,372
+1,607,523
+161% +$36.1M 0.32% 71
2025
Q1 		$24M Sell
1,000,849
-201,617
-17% -$6.48M 0.16% 191
2024
Q4 		$50.9M Buy
1,202,466
+201,573
+20% +$8.92M 0.34% 79
2024
Q3 		$44.2M Buy
1,000,893
+51,976
+5% +$1.97M 0.37% 79
2024
Q2 		$34.3M Buy
948,917
+1,820
+0.2% +$72.2K 0.33% 86
2024
Q1 		$40.8M Sell
947,097
-1,560,043
-62% -$55.6M 0.38% 78
2023
Q4 		$38.6M Sell
2,507,140
-55,460
-2% -$704K 0.42% 67
2023
Q3 		$35.1M Buy
2,562,600
+808,910
+46% +$13.9M 0.41% 56
2023
Q2 		$28.1M Buy
1,753,690
+972
+0.1% +$8.78K 0.33% 90
2023
Q1 		$13.6M Buy
1,752,718
+1,603,165
+1,072% +$12.4M 0.19% 158
2022
Q4 		$2.89M Sell
149,553
-19,724
-12% -$357K 0.04% 421
2022
Q3 		$3.61M Buy
+169,277
New +$3.17M 0.05% 354

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Woodline Partners's VERA Position: Q1 2026 in Review

Woodline Partners increased its Vera Therapeutics (VERA) stake by 0.08% in Q1 2026, buying an estimated $32.7K and bringing the position to 1,001,037 shares worth $40.3M. The position accounts for 0.15% of the portfolio, ranked #173.

Woodline Partners first reported a position in VERA in Q3 2022 and has held it in 15 quarters since. The position peaked at $61.5M in Q2 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Woodline Partners held 1,001,037 shares of Vera Therapeutics worth $40.3M as of Q1 2026.
  • Woodline Partners bought 758 Vera Therapeutics shares in Q1 2026, an estimated $32.7K.
  • Vera Therapeutics made up 0.15% of Woodline Partners's portfolio in Q1 2026, its #173 holding.
  • Woodline Partners first reported a position in Vera Therapeutics in Q3 2022 and has held it in 15 quarters since.
  • Woodline Partners's Vera Therapeutics position peaked at $61.5M in Q2 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.